C-CD3EAni Biome
multiomics, digital phenotyping, AI state modeling
consumer products
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-CD3E
C-CD3EC-CD3Emultiomics, digital phenotyping, AI state modeling
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Ani Biome multiomics, digital phenotyping, AI state modeling
Ani Biome is a San Francisco research lab developing a computational substrate for longevity medicine. Its ANI platform integrates deep multiomics, longitudinal digital phenotyping, functional and cognitive assessments, intervention exposure, and physician decisions into a learned model of human biological state. The company is running ELITE, a healthspan intervention trial at Sheba Medical Center, and was selected for both the XPRIZE Healthspan competition and the FSHD Bonus Prize in May 2025.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Ani Biome — Far from goals · Bottom quartile. Derived deterministically from 7 extracted project(s). Most-advanced status: exploratory. Band: far. Modifiers: +5 depth (4 programs at exploratory).…
Source: Deterministic